CLINICAL_TRIALS
research
· 2025-05-13
Clinical Trial Update: Fostemsavir Compassionate Use Named Patient Program for the Treatment of Human Immunodeficiency Virus 1 (HIV-1)
Summary
This clinical-trial update describes ViiV Healthcare's compassionate-use named-patient program for fostemsavir to treat HIV-1 infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: HIV Infections | Status: AVAILABLE